Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management, and Prevention of COPD [updated December 2010] Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdfAccessed April 13, 2011
   Google Scholar
• World Health OrganizationChronic obstructive pulmonary disease Fact sheet No. 315. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed August 26, 2011
   Google Scholar
• ToyELGallagherKFStanleyELSwensenARDuhMSThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD20107321422820486821
   PubMedGoogle Scholar
• ManninoDMBuistASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet2007370958976577317765526
   PubMed Web of Science ®Google Scholar
• BourbeauJFordGZackonHPinskyNLeeJRubertoGImpact on patients’ health status following early identification of a COPD exacerbationEur Respir J200730590791317715163
   PubMed Web of Science ®Google Scholar
• DonaldsonGCWedzichaJACOPD exacerbations.1: EpidemiologyThorax200661216416816443707
   PubMed Web of Science ®Google Scholar
• O’ReillyJFWilliamsAEHoltKRiceLDefining COPD exacerbations: impact on estimation of incidence and burden in primary carePrim Care Respir J200615634635317064963
   PubMedGoogle Scholar
• Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
   PubMed Web of Science ®Google Scholar
• StevensonNJWalkerPPCostelloRWCalverleyPMLung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172121510151616166620
   PubMed Web of Science ®Google Scholar
• HurstJRDonaldsonGCQuintJKGoldringJJBaghai-RavaryRWedzichaJATemporal clustering of exacerbations in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009179536937419074596
   PubMed Web of Science ®Google Scholar
• AdamsSGMeloJLutherMAnzuetoAAntibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPDChest200011751345135210807821
   PubMed Web of Science ®Google Scholar
• McGhanRRadcliffTFishRSutherlandERWelshCMakeBPredictors of rehospitalization and death after a severe exacerbation of COPDChest200713261748175517890477
   PubMed Web of Science ®Google Scholar
• MurataGHGorbyMSChickTWHalperinAKTreatment of decompensated chronic obstructive pulmonary disease in the emergency department – correlation between clinical features and prognosisAnn Emerg Med19912021251291996791
   PubMed Web of Science ®Google Scholar
• PatilSPKrishnanJALechtzinNDietteGBIn-hospital mortality following acute exacerbations of chronic obstructive pulmonary diseaseArch Intern Med2003163101180118612767954
   PubMed Web of Science ®Google Scholar
• Ai-PingCLeeKHLimTKIn-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective studyChest2005128251852416100133
   PubMed Web of Science ®Google Scholar
• LindenauerPKPekowPGaoSCrawfordASGutierrezBBenjaminEMQuality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med20061441289490316785478
   PubMed Web of Science ®Google Scholar
• YipNHYuenGLazarEJAnalysis of hospitalizations for COPD exacerbation: opportunities for improving careCOPD201072859220397808
   PubMedGoogle Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• MurphyTFBrauerALEschbergerKPseudomonas aeruginosa in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008177885386018202344
   PubMed Web of Science ®Google Scholar
• BonhoefferJBarGRiffelmannMSolerMHeiningerUThe role of Bordetella infections in patients with acute exacerbation of chronic bronchitisInfection2005331131715750754
   PubMed Web of Science ®Google Scholar
• SchneiderDGanesanSComstockATIncreased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010182333234020395558
   PubMed Web of Science ®Google Scholar
• DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
   PubMed Web of Science ®Google Scholar
• BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax200055211412010639527
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTAPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest200512841995200416236847
   PubMed Web of Science ®Google Scholar
• SpruitMAGosselinkRTroostersTMuscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-IThorax200358975275612947130
   PubMed Web of Science ®Google Scholar
• HolguinFFolchEReddSCManninoDMComorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001Chest200512842005201116236848
   PubMed Web of Science ®Google Scholar
• LangsetmoLPlattRWErnstPBourbeauJUnderreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohortAm J Respir Crit Care Med2008177439640118048806
   PubMed Web of Science ®Google Scholar
• MarinJMCarrizoSJCasanovaCPrediction of risk of COPD exacerbations by the BODE indexRespir Med2009103337337819013781
   PubMed Web of Science ®Google Scholar
• JonesRCDonaldsonGCChavannesNHDerivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE IndexAm J Respir Crit Care Med2009180121189119519797160
   PubMed Web of Science ®Google Scholar
• LeidyNKWilcoxTKJonesPWRobertsLPowersJHSethiSStandardizing measurement of chronic obstructive pulmonary disease exacerbations: reliability and validity of a patient-reported diaryAm J Respir Crit Care Med2011183332332920813886
   PubMed Web of Science ®Google Scholar
• StolzDChrist-CrainMBingisserRAntibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapyChest2007131191917218551
   PubMed Web of Science ®Google Scholar
• LacomaAPratCAndreoFValue of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011615716921468168
   PubMed Web of Science ®Google Scholar
• BazeghiNGerdsTABudtz-JorgensenEHoveJVestboJExhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPDRespir Med201110591338134421530214
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• KestenSCelliBDecramerMLeimerITashkinDTiotropium HandiHaler in the treatment of COPD: a safety reviewInt J Chron Obstruct Pulmon Dis2009439740920037679
   PubMedGoogle Scholar
• SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med2008359222355236519038881
   PubMed Web of Science ®Google Scholar
• RoedeBMBresserPBindelsPJAntibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort studyThorax2008631196897318682520
   PubMed Web of Science ®Google Scholar
• El MoussaouiRRoedeBMSpeelmanPBresserPPrinsJMBossuytPMShort-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studiesThorax200863541542218234905
   PubMed Web of Science ®Google Scholar
• DimopoulosGSiemposIIKorbilaIPMantaKGFalagasMEComparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trialsChest2007132244745517573508
   PubMed Web of Science ®Google Scholar
• DanielsJMSnijdersDde GraaffCSVlaspolderFJansenHMBoersmaWGAntibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181215015719875685
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• MehtaSHillNSNoninvasive ventilationAm J Respir Crit Care Med2001163254057711179136
   PubMed Web of Science ®Google Scholar
• AuDHBrysonCLChienJWThe effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbationsJ Gen Intern Med200924445746319194768
   PubMed Web of Science ®Google Scholar
• NicholKLBakenLNelsonARelation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung diseaseAnn Intern Med1999130539740310068413
   PubMed Web of Science ®Google Scholar
• Advisory Committee on Immunization PracticesRecommended adult immunization schedule: United States, 2011Ann Intern Med2011154316817321282696
   PubMed Web of Science ®Google Scholar
• KretsingerKBroderKRCorteseMMPreventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnelMMWR Recomm Rep200655RR-17137
   Google Scholar
• SeemungalTAWilkinsonTMHurstJRPereraWRSapsfordRJWedzichaJALong-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med2008178111139114718723437
   PubMed Web of Science ®Google Scholar
• AlbertRKBaileyWCCasaburiRChronic azithromycin decreases the frequency of chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med2011183A6416
   Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med2005143531732616144890
   PubMed Web of Science ®Google Scholar
• FergusonGTAnzuetoAFeiREmmettAKnobilKKalbergCEffect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbationsRespir Med200810281099110818614347
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• TashkinDPRennardSIMartinPEfficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trialDrugs200868141975200018778120
   PubMed Web of Science ®Google Scholar
• RennardSITashkinDPMcElhattanJEfficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trialDrugs200969554956519368417
   PubMed Web of Science ®Google Scholar
• WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
   PubMed Web of Science ®Google Scholar
• Prescribing information for Daliresp^™ (roflumilast) tablets: initial US approval2011 Available from: http://www.frx.com/pi/Daliresp_pi.pdfAccessed March 7, 2011
   Google Scholar
• BourbeauJBartlettSJPatient adherence in COPDThorax200863983183818728206
   PubMed Web of Science ®Google Scholar
• RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis20083337138418990964
   PubMedGoogle Scholar
• BarrRGCelliBRManninoDMComorbidities, patient knowledge, and disease management in a national sample of patients with COPDAm J Med2009122434835519332230
   PubMed Web of Science ®Google Scholar
• SarcIJericTZiherlKAdherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary diseaseJ Eval Clin Pract Epub 2011 Jan 11
   Web of Science ®Google Scholar
• FinkJHodderRAdherence and inhaler devices in COPDRespir Ther201162833
   Google Scholar
• Riario-SforzaGGYacoubMRIncorvaiaCPulmonary rehabilitation as evaluated by clinical trials: an overviewRev Recent Clin Trials201052768420201797
   PubMedGoogle Scholar
• PuhanMAScharplatzMTroostersTSteurerJRespiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – a systematic reviewRespir Res200565415943867
   PubMed Web of Science ®Google Scholar
• AmbrosinoNFoglioKBalzanoGPaggiaroPLLessiPKestenSTiotropium and exercise training in COPD patients: effects on dyspnea and exercise toleranceInt J Chron Obstruct Pulmon Dis20083477178019281092
   PubMedGoogle Scholar
• ManWDPolkeyMIDonaldsonNGrayBJMoxhamJCommunity pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled studyBMJ20043297476120915504763
   PubMed Web of Science ®Google Scholar
• RaskinJSpieglerPMcCuskerCThe effect of pulmonary rehabilitation on healthcare utilization in chronic obstructive pulmonary disease: The Northeast Pulmonary Rehabilitation ConsortiumJ Cardiopulm Rehabil200626423123616926687
   PubMedGoogle Scholar
• ChatilaWMThomashowBMMinaiOACrinerGJMakeBJComorbidities in chronic obstructive pulmonary diseaseProc Am Thorac Soc20085454955518453370
   PubMedGoogle Scholar
• KinnunenTSaynajakangasOTuuponenTKeistinenTImpact of comorbidities on the duration of COPD patients’ hospital episodesRespir Med200397214314612587964
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEEnrightPLManfredaJHospitalizations and mortality in the Lung Health StudyAm J Respir Crit Care Med2002166333333912153966
   PubMed Web of Science ®Google Scholar
• CalverleyPMSanchez-TorilFMcIvorATeichmannPBredenbroekerDFabbriLMEffect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007176215416117463412
   PubMed Web of Science ®Google Scholar
• DicksteinKCohen-SolalAFilippatosGESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Eur J Heart Fail2008101093398918826876
   PubMed Web of Science ®Google Scholar
• van GestelYRHoeksSESinDDImpact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosisAm J Respir Crit Care Med2008178769570018565952
   PubMed Web of Science ®Google Scholar
• RuttenFHZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med20101701088088720498416
   PubMed Web of Science ®Google Scholar
• Canadian Thoracic SocietyCOPD action plan2008 [updated 2008 Oct 20]. Available from: http://www.lung.ca/pdf/1408_THOR_ActionPlan_v3.pdfAccessed August 26, 2011
   Google Scholar
• EffingTMonninkhofEMvan der ValkPDSelf-management education for patients with chronic obstructive pulmonary diseaseCochrane Database Syst Rev20074CD00299017943778
   PubMed Web of Science ®Google Scholar
• Wood-BakerRMcGloneSVennAWaltersEHWritten action plans in chronic obstructive pulmonary disease increase appropriate treatment for acute exacerbationsRespirology200611561962616916336
   PubMed Web of Science ®Google Scholar
• SedenoMFNaultDHamdDHBourbeauJA self-management education program including an action plan for acute COPD exacerbationsCOPD20096535235819863364
   PubMedGoogle Scholar
• HurstJRFitzgerald-KhanFQuintJKUse and utility of a 24-hour telephone support service for ‘high risk’ patients with COPDPrim Care Respir J201019326026520571731
   PubMedGoogle Scholar
• NaunheimKSWoodDEMohsenifarZLong-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research GroupAnn Thorac Surg200682243144316888872
   PubMed Web of Science ®Google Scholar
• WashkoGRFanVSRamseySDThe effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med2008177216416917962632
   PubMed Web of Science ®Google Scholar